Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,216 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,855 | N/A | N/A | N/A | N/A |
| Gross Profit | -639 | N/A | N/A | N/A | N/A |
| Operating Expenses | 29,927 | 22,239 | 15,202 | 18,849 | 11,140 |
| Operating Income | -29,711 | -22,239 | -15,202 | -18,849 | -11,140 |
| Interest Expense | 252 | -299 | 216 | 217 | 28 |
| Other Income | -1,223 | -486 | -336 | -309 | 0 |
| Pre-tax Income | -31,186 | -22,426 | -15,754 | -19,375 | -11,168 |
| Income Tax | -1,254 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -29,932 | -22,426 | -15,754 | -19,375 | -11,168 |
| Net Income | $-29,932 | $-22,426 | $-15,754 | $-19,375 | $-11,168 |
| EPS Basic Total Ops | -9.20 | -8.80 | -8.40 | -12.80 | -8.40 |
| EPS Basic Continuous Ops | -9.14 | -8.74 | -8.32 | -12.83 | -8.42 |
| EPS Diluted Total Ops | -9.20 | -8.80 | -8.40 | -12.80 | -8.40 |
| EPS Diluted Continuous Ops | -9.14 | -8.74 | -8.32 | -12.83 | -8.42 |
| EPS Diluted Before Non-Recurring Items | -9.20 | -8.80 | N/A | N/A | N/A |
| EBITDA(a) | $-28,793 | $-21,792 | $-13,923 | $-18,186 | $-10,753 |